Menu
Your Cart

Apostle NanoFlex 800 Micro-Spectrophotometer + Fluorometer

Apostle NanoFlex 800 Micro-Spectrophotometer + Fluorometer
Apostle NanoFlex 800 Micro-Spectrophotometer + Fluorometer
Apostle NanoFlex 800 Micro-Spectrophotometer + Fluorometer
Apostle NanoFlex 800 Micro-Spectrophotometer + Fluorometer
Secured Shopping
Best security features
Apostle NanoFlex 800 Micro-Spectrophotometer + Fluorometer

Apostle NanoFlex 800 is a spectrophotometer that measures 0.5μL-2μL samples with high accuracy and reproducibility.   In addition, the Apostle NanoFlex 800 has the built-in fluorescence detection function, and can work as a fluorometer.  It has capability to measure highly concentrated samples without dilution (100X higher concentration than the samples measured by a standard cuvette).   


Model

Apostle NanoFlex 800

Minimum Sample Size

0.5μL-2μL (2μL recommended)

Path Length

0.05 , 0.2mm or 1mm

Light Source / Life

Xenon flash lamp / >109 flashes

Detector Type

2048—element linear silicon CCD array

Wavelength Range

200—800nm

Wavelength Accuracy

±1 nm

Spectral Resolution

≤3nm(FWHM@Hg 253.7nm)

Absorbance Precision  

0.003Abs(1mm path length)

Absorbance Accuracy

±1%(7.332Abs, at 260nm wavelength)

Absorbance Range

0.04—300(at 260 wavelength, 10mm equivalent)

Detection Concentration Range

2ng/μL dsDNA ~15,000ng/μL dsDNA

Detection Time

<6 seconds

OD600

Abs range

0~4.000 Abs

Abs stability

[0,3)≤0.5%   [3,4)≤2%

Abs repeatability

[0,3)≤0.5%   [3,4)≤2%

Abs Precision

[0,2)≤0.005A;[2,3)≤1%;[3,4)≤2%

Fluorometer

Linearity

R2≥0.995

Repeatability

  1.5%

Stability

  1.5%

Voltage input

DC24V  2A

Power

25W

Dimension

208×320×186 mm(W×D×H)

Weight

3.6 kg



$8,975.25
A new clinical study, led by scientists from MD Anderson Cancer Center and published in Cancer Cell (journal impact factor = 50.3), shows that tumor and cfDNA methylation can be used to identify SCLC subtypes and might guide precision SCLC therapy. Apostle MiniMax cfDNA kit is one of the critical commercial assays listed in this article. Congratulations to this clinical research team. To date, the Apostle MiniMax technology has been used in 2 articles published in Nature Communications, 2 in Nature Medicine, 1 in Science Translational Medicine, 1 in PNAS, and over 60 scientific articles by over 60 international research and clinical teams in different journals.